Novo Integrated Sciences Inc (NASDAQ:NVOS) — Stock Price
Novo Integrated Sciences Inc (NASDAQ:NVOS) is currently trading at $0.00 USD, up 0.00% today. Over the past 52 weeks, shares have ranged between $0.00 and $0.06. This page tracks Novo Integrated Sciences Inc's live share price on the NASDAQ exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see how much is Novo Integrated Sciences Inc worth.
Novo Integrated Sciences Inc (NVOS) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Novo Integrated Sciences Inc's daily closing share price and trading volume on the NASDAQ exchange over the past year, giving a clear view of recent price momentum and liquidity.
Novo Integrated Sciences Inc Income Statement — Revenue, Profit & Earnings by Year
Novo Integrated Sciences Inc's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Revenue | $13.29 Million | $12.57 Million | $11.74 Million | $9.31 Million | $7.86 Million |
| Cost of Revenue | $7.55 Million | $7.62 Million | $6.94 Million | $5.48 Million | $4.80 Million |
| Gross Profit | $5.74 Million | $4.95 Million | $4.80 Million | $3.82 Million | $3.06 Million |
| Research & Development | — | — | — | — | — |
| SG&A | $14.04 Million | $13.49 Million | $14.36 Million | $8.09 Million | $7.29 Million |
| Total Operating Expenses | $14.06 Million | $13.51 Million | $22.89 Million | $8.20 Million | $7.29 Million |
| Operating Income | $-8.31 Million | $-8.55 Million | $-25.03 Million | $-4.27 Million | $-4.26 Million |
| EBITDA | $-10.08 Million | $-5.85 Million | $-28.41 Million | $-2.58 Million | $-2.78 Million |
| EBIT | $-16.78 Million | $-8.15 Million | $-31.43 Million | $-4.31 Million | $-4.77 Million |
| Interest Expense | $652.40K | $5.12 Million | $1.59 Million | $165.00K | $156.66K |
| Income Before Tax | $-16.13 Million | $-13.27 Million | $-33.07 Million | $-4.47 Million | $-4.92 Million |
| Income Tax Expense | — | $-22.30K | $22.30K | $178.12K | $-46.45K |
| Net Income | $-16.13 Million | $-13.21 Million | $-33.05 Million | $-4.46 Million | $-4.92 Million |
Novo Integrated Sciences Inc Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Novo Integrated Sciences Inc's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Assets | $32.14 Million | $35.56 Million | $71.79 Million | $61.96 Million | $35.39 Million |
| Total Current Assets | $5.41 Million | $4.39 Million | $20.08 Million | $11.13 Million | $4.29 Million |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | — | — | — | — | — |
| Net Receivables | $3.15 Million | $1.47 Million | $6.38 Million | $2.28 Million | $2.04 Million |
| Inventory | $1.00 Million | $1.11 Million | $645.06K | $339.38K | $1.00 |
| Property, Plant & Equipment | — | — | — | $8.61 Million | $3.16 Million |
| Goodwill | $6.55 Million | $7.58 Million | $11.37 Million | $9.49 Million | $636.94K |
| Total Liabilities | $17.53 Million | $11.06 Million | $27.36 Million | $18.15 Million | $5.82 Million |
| Total Current Liabilities | $14.58 Million | $7.90 Million | $12.73 Million | $8.46 Million | $2.60 Million |
| Long-term Debt | — | $65.04K | $1.11 Million | $6.12 Million | $952.06K |
| Net Debt | $3.87 Million | $4.06 Million | $7.17 Million | $5.42 Million | $2.33 Million |
| Total Stockholder Equity | $14.89 Million | $24.82 Million | $44.43 Million | $43.86 Million | $29.62 Million |
| Retained Earnings | $-83.20 Million | $-67.03 Million | $-31.39 Million | $-20.97 Million | $-16.51 Million |
Novo Integrated Sciences Inc Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Novo Integrated Sciences Inc generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Cash Flow | $-2.24 Million | $-2.24 Million | $-5.88 Million | $-1.02 Million | $-441.69K |
| Capital Expenditures | $49.22K | $49.22K | $190.17K | $255.95K | $12.11K |
| Free Cash Flow | $-2.29 Million | $-2.29 Million | $-6.07 Million | $-1.28 Million | $-453.80K |
| Investing Cash Flow | $-49.22K | $-49.22K | — | $3.00 Million | $657.13K |
| Financing Cash Flow | $763.86K | $763.86K | $-427.12K | $4.32 Million | $-271.69K |
| Dividends Paid | — | — | — | — | — |
| Stock-Based Compensation | — | $385.33K | $426.69K | $155.50K | $2.33 Million |
| Depreciation | $2.30 Million | $2.30 Million | $3.02 Million | $1.72 Million | $1.45 Million |
| Change in Cash | $-1.76 Million | $-1.76 Million | $-6.11 Million | $6.23 Million | $-15.95K |
Novo Integrated Sciences Inc Earnings History — EPS Actual vs. Analyst Estimates
Track Novo Integrated Sciences Inc's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Dec 18, 2024 | 0.26 | 0.00 | — |
| Aug 31, 2024 | 0.26 | — | — |
| Jul 19, 2024 | -0.74 | — | — |
| Apr 15, 2024 | -0.16 | — | — |
| Jan 22, 2024 | -0.28 | — | — |
| Aug 31, 2023 | -0.20 | — | — |
| Jul 17, 2023 | -0.01 | — | — |
| May 26, 2023 | -1.13 | — | — |